Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: What is the New Jersey Water Contamination PFAS lawsuit?
Answer: The New Jersey Water Contamination PFAS lawsuit includes both state-specific litigation and participation in the federal multidistrict litigation (MDL 2873) consolidating thousands of cases against chemical manufacturers who polluted drinking water supplies with toxic forever chemicals.
On this page, we’ll discuss this question in further depth, health conditions linked to PFAS Water Contamination, and much more.
New Jersey’s aggressive legal action resulted in a $450 million settlement with 3M in May 2025, addressing statewide contamination linked to DuPont’s Chambers Works facility and other industrial sites.
The litigation includes claims from water utilities seeking cleanup costs, municipalities demanding infrastructure upgrades, and individual residents diagnosed with cancer and other serious health conditions after drinking contaminated water. PFAS manufacturers face increasing pressure to settle claims as evidence mounts regarding their knowledge of contamination risks.
Additional settlements totaling over $700 million have been reached with BASF and Solvay, while personal injury cases continue advancing toward bellwether trials scheduled for October 2025 in federal court.
If you or someone you love has medical proof of PFAS-related disease, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can help you determine if you qualify to file a PFAS Water Contamination Lawsuit today.
Per- and polyfluoroalkyl substances (PFAS), known as “forever chemicals,” have been infiltrating New Jersey’s water systems since their introduction in the 1940s for industrial and military applications.
These synthetic chemicals, which include thousands of compounds engineered to resist heat, water, and oil, persist indefinitely in the environment and accumulate in human bodies over decades.
Originally developed for use in nonstick cookware and firefighting foam, PFAS have spread throughout the environment.
New Jersey faces severe contamination due to its dense concentration of military installations, chemical manufacturing facilities, and industrial sites that have used PFAS-containing products for over 70 years.
The Environmental Working Group has documented extensive PFAS pollution across the state’s watersheds.
New Jersey’s PFAS contamination affecting drinking water sources stems from multiple sources that have discharged these chemicals into groundwater, surface water, and soil for decades through industrial processes, firefighting activities, and waste disposal.
The state’s unique combination of military bases using aqueous film-forming foam (AFFF), major chemical manufacturers producing PFAS compounds, and numerous industrial facilities has created widespread contamination affecting both public water systems and private wells.
Primary sources of PFAS contamination in New Jersey include:
These sources have resulted in 63% of community water systems tested by NJDEP from 2019-2021 showing PFAS detections, affecting 84% of New Jersey’s population according to research published by the National Institute of Environmental Health Sciences.
Historical industrial practices allowed these chemicals to be discharged directly into waterways and soil without treatment, while military bases conducted decades of fire suppression training that saturated the ground with PFAS-laden foam.
New Jersey emerged as a national leader in PFAS detection and regulation, becoming the first state to propose enforceable drinking water standards for these chemicals in 2018 and establishing some of the strictest limits in the nation. The state has a long history of industrial activity that contributed to widespread contamination.
The state’s proactive approach revealed the shocking extent of contamination, with testing showing that PFAS chemicals had infiltrated water supplies serving millions of residents across all 21 counties.
These alarming findings prompted immediate action on regulating PFAS at the state level.
Key milestones in New Jersey’s PFAS response feature:
Recent testing data reveals that 63% of New Jersey’s community water systems contain detectable PFAS levels, collectively serving 84% of the state’s population receiving public water.
The contamination continues to spread as more testing uncovers previously unknown pollution sites, with private well owners discovering contamination during real estate transactions and voluntary testing programs.
The Environmental Protection Agency’s new enforceable limit of 4 parts per trillion (ppt) for PFOA and PFOS represents an extremely low threshold that many New Jersey communities exceed by factors of 10 to 100 times.
These federal regulations for safe drinking water aim to protect public health from serious health risks associated with PFAS exposure.
Testing from 2019-2021 revealed that nearly one-quarter of New Jersey residents received water exceeding the state’s maximum contaminant levels, while 72% were served by systems exceeding the EPA’s proposed stricter standards.
Water quality monitoring shows certain PFAS compounds at alarming high concentrations throughout the state.
Water systems with documented PFAS contamination (among others):
The New Jersey Department of Environmental Protection maintains an active database tracking PFAS levels across 491 tested community water systems, with quarterly monitoring revealing both progress in remediation efforts and ongoing discoveries of new contamination.
Testing also reveals other contaminants alongside PFAS in many water systems.
Water utilities face enormous challenges in meeting the strict standards, requiring installation of specialized treatment systems costing millions of dollars while contamination sources remain active in many locations.
Communities across the country face similar challenges with PFAS contamination.
If you or a loved one developed cancer or other serious health conditions after exposure to PFAS-contaminated water in New Jersey, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a New Jersey PFAS water contamination lawsuit today.
Decades of scientific research, including studies by the Centers for Disease Control and Prevention (CDC) and Environmental Protection Agency (EPA), have established definitive links between PFAS exposure and specific cancers, chronic diseases, and reproductive health conditions.
Medical diagnosis timing plays a fundamental role in lawsuit eligibility, with most cases requiring diagnosis after January 1, 2000, following documented exposure to contaminated water supplies. These high levels of PFAS in the body can break down normal cellular functions.
The growing body of epidemiological evidence continues to strengthen the connection between PFAS blood serum levels and serious health outcomes, providing the scientific foundation for legal claims against responsible parties.
Scientific studies have identified four primary cancer types with the strongest epidemiological links to PFAS exposure, particularly kidney cancer (renal cell carcinoma), which shows elevated risk ratios in populations with contaminated drinking water.
The C8 Science Panel, formed after a major PFAS contamination case, established probable links between PFOA exposure and both kidney and testicular cancers through extensive health studies involving over 69,000 participants.
Cancers scientifically linked to PFAS exposure consist of:
Research demonstrates that cancer risks increase proportionally with both exposure concentration and duration, with some studies showing doubled or tripled cancer rates in heavily exposed communities compared to background populations.
PFAS chemicals have also been linked to food contamination through agricultural irrigation with contaminated water.
The latency period between initial exposure and cancer diagnosis can span decades, making it challenging to establish direct causation without comprehensive exposure documentation and medical expert testimony.
Beyond cancer diagnoses, PFAS exposure disrupts multiple body systems through mechanisms including immune suppression, hormonal interference, and metabolic dysfunction, leading to chronic conditions that can impact quality of life.
The C8 Science Panel identified ulcerative colitis as having a probable link to PFOA exposure, representing one of the few non-cancer conditions with definitive epidemiological evidence supporting causation.
Qualifying non-cancer conditions linked to PFAS involve:
These conditions must be medically documented with clear diagnostic criteria and show temporal relationship to PFAS exposure periods, typically requiring years of contaminated water consumption before disease manifestation.
Medical research indicates that certain populations, including pregnant women, children, and individuals with pre-existing conditions, face heightened vulnerability to PFAS-related health effects at lower exposure levels.
If you or a loved one suffered from kidney cancer, testicular cancer, ulcerative colitis, or other PFAS-related conditions after drinking contaminated water, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a New Jersey PFAS water contamination lawsuit today.
Successful PFAS litigation requires comprehensive medical documentation establishing both the diagnosis and its relationship to contaminated water exposure, with attorneys working alongside medical experts to build compelling causation arguments.
Complete medical records serve as the foundation for calculating damages and demonstrating the full impact of PFAS-related diseases on plaintiffs’ lives, employment, and future medical needs. Attorneys may request other documents to strengthen your case beyond medical records.
Medical documentation for PFAS claims includes tactics like:
Organizing medical records chronologically helps establish disease progression timelines that correspond with exposure periods, strengthening the causal link between contaminated water consumption and subsequent health impacts.
Attorneys specializing in PFAS litigation typically partner with medical record retrieval services that can obtain documentation from multiple healthcare providers, including records from facilities that have closed or changed ownership over the decades-long exposure periods.
Eligibility for PFAS litigation requires meeting specific criteria encompassing exposure history, medical diagnosis, and timing requirements that align with New Jersey’s legal framework for toxic tort claims.
Both current and former New Jersey residents may pursue compensation if they consumed contaminated water for sufficient duration and subsequently developed qualifying health conditions within the applicable statute of limitations.
The foundation of any PFAS claim rests on demonstrating sufficient exposure to contaminated water, with most attorneys requiring a minimum one-year residence or employment in affected areas between 1970 and the present.
This exposure period recognizes that PFAS accumulates in the human body over time, with longer exposure durations generally correlating with higher blood serum levels and increased health risks.
Qualifying PFAS exposure scenarios include, but are not limited to:
Proving exposure requires documentation such as utility bills showing service addresses, property deeds or rental agreements, employment records confirming work locations, or sworn affidavits from family members who can attest to residence history.
Military personnel can use service records and base assignment documentation, while students may provide enrollment records and dormitory assignments to establish their presence in contaminated areas during the relevant timeframe.
New Jersey’s two-year statute of limitations for personal injury claims begins running from the date of diagnosis, not from the initial exposure, creating a narrow window for legal action that requires prompt attention.
The discovery rule may extend this deadline in certain circumstances where plaintiffs could not reasonably have known about the contamination’s role in their illness, though courts apply this exception sparingly.
Timing considerations in PFAS claims may include:
Missing the statute of limitations permanently bars compensation claims regardless of injury severity or exposure levels, making immediate legal consultation imperative upon receiving a qualifying diagnosis.
If you’ve been diagnosed with cancer or chronic conditions linked to PFAS exposure within the past two years, time is running out to file your claim.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a New Jersey PFAS water contamination lawsuit today.
Military service members and firefighters face dramatically elevated PFAS exposure risks through occupational contact with aqueous film-forming foam (AFFF) used in training exercises and emergency responses, often combined with residential exposure from base housing water systems.
These dual exposure pathways create particularly strong legal claims, as plaintiffs can demonstrate both direct occupational contact and consumption of contaminated drinking water over extended periods.
PFAS exposure factors for military and firefighters demonstrate the following patterns:
Documentation through DD-214 forms showing military occupational specialties, training records confirming firefighting exercises, and base assignment histories strengthen these claims by establishing clear exposure pathways.
Veterans receiving VA disability benefits for PFAS-related conditions maintain the right to pursue civil litigation against chemical manufacturers, as government benefits address service-connected disabilities while lawsuits target corporate defendants who knowingly sold harmful products.
New Jersey’s aggressive pursuit of PFAS polluters has yielded historic settlements, including the landmark $450 million agreement with 3M announced in May 2025 and the $393 million Solvay settlement, demonstrating the state’s commitment to holding chemical manufacturers financially accountable.
These state-level settlements address environmental remediation and water system upgrades, while individual plaintiffs pursue separate compensation through personal injury claims that can result in substantial awards based on injury severity and exposure documentation.
The momentum from these victories positions New Jersey plaintiffs favorably as litigation continues against remaining defendants like DuPont and Chemours.
The May 2025 settlement with 3M represents the largest PFAS-related agreement in New Jersey history, resolving claims just days before a scheduled trial that would have been the nation’s first to determine state-level environmental PFAS liability.
This $450 million agreement, payable over 25 years with substantial front-loading in the first four years, stems from 3M’s decades-long supply of PFAS compounds to DuPont’s Chambers Works facility in Salem County.
Major PFAS settlements affecting New Jersey consist of:
These settlements allocate funds across multiple categories including natural resource damages ($140 million from 3M), drinking water treatment infrastructure, long-term monitoring programs, and litigation costs, with portions specifically earmarked for communities most severely impacted by contamination.
The agreements establish precedents for corporate accountability while providing immediate resources for remediation efforts, though environmental advocates question whether the amounts adequately address the full scope of contamination discovered across New Jersey’s water systems.
The corporate settlement amounts listed above represent negotiated agreements for environmental remediation and water system upgrades.
Individual plaintiff compensation is separate from these figures and will vary based on personal circumstances.
These historical settlements provide context but do not guarantee similar outcomes in pending or future cases.
Individual PFAS plaintiffs can expect compensation ranges vary based on medical diagnosis severity, exposure duration, age at diagnosis, and quality of supporting documentation, with settlements typically structured in tiers reflecting these factors.
Industry analysts and attorneys handling PFAS cases project individual settlements ranging from $30,000 for lower-tier cases to over $500,000 for plaintiffs with severe cancers and compelling exposure evidence.
Projected settlement tiers for individual plaintiffs involve methods such as:
These projections are derived from comparable mass tort settlements involving environmental contamination and toxic exposure, with PFAS cases potentially commanding higher values due to the chemicals’ persistence in human bodies and the clear corporate knowledge of health risks.
Settlement negotiations consider both economic damages, such as medical expenses and lost wages, alongside non-economic damages for pain, suffering, and diminished quality of life resulting from PFAS-related diseases.
Please be advised that the settlement amounts mentioned above are general estimations and are not guaranteed.
They are meant to provide a general idea of potential settlement ranges and should not be taken as definitive expectations for your case.
If you’ve been diagnosed with cancer or other serious conditions from PFAS exposure, you deserve maximum compensation for your suffering.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a New Jersey PFAS water contamination lawsuit today.
Certain case characteristics can dramatically increase settlement values, particularly for younger plaintiffs whose life expectancy and earning potential face greater impact from PFAS-related diseases requiring lifelong medical management.
Key factors in determining the settlement value of your claim may include:
Plaintiffs who proactively document their damages through detailed medical treatment records, economic loss calculations, and impact statements describing how PFAS-related illnesses affected their daily lives typically achieve superior settlement outcomes compared to those with sparse documentation.
Our PFAS Contamination attorney at TruLaw is dedicated to supporting clients through the process of filing a PFAS Contamination lawsuit.
With extensive experience in chemical exposure cases, Jessica Paluch-Hoerman and our partner law firms work with litigation leaders to prove how toxic PFAS chemicals in water supplies caused you harm.
TruLaw focuses on securing compensation for medical expenses, pain and suffering, property damage, lost income, and ongoing health monitoring resulting from your PFAS exposure.
We understand the health and environmental impacts of PFAS exposure on your life and provide the personalized guidance you need when seeking justice.
Meet our lead PFAS Contamination attorney:
At TruLaw, we believe financial concerns should never stand in the way of justice.
That’s why we operate on a contingency fee basis—with this approach, you only pay legal fees after you’ve been awarded compensation for your injuries.
If you or a loved one experienced health complications from exposure to PFAS-contaminated water that include forms of cancer, immune disorders, liver damage, or thyroid disease, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a PFAS Contamination Lawsuit today.
PFAS contamination lawsuits are being filed by individuals nationwide who experienced health problems from exposure to PFAS chemicals in drinking water.
TruLaw is currently accepting clients for the PFAS contamination lawsuit.
A few reasons to choose TruLaw for your PFAS contamination lawsuit include:
If you or a loved one suffered health problems related to PFAS-contaminated water, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the PFAS Contamination Lawsuit today.
Four cancers have the strongest scientific links to PFAS exposure: kidney cancer (renal cell carcinoma), testicular cancer, liver cancer, and thyroid cancer.
New Jersey plaintiffs diagnosed with these cancers after January 1, 2000, following at least 12 months of contaminated water consumption, may qualify for settlements ranging from $150,000 to $375,000 based on exposure documentation and age at diagnosis.
The settlement range mentioned above is a general estimation based on legal expert projections and is not guaranteed.
Actual settlement amounts depend on numerous factors unique to each situation.
Contact TruLaw using the chat on this page for a personalized case evaluation.
New Jersey’s statute of limitations gives you exactly 2 years from your diagnosis date to file a PFAS lawsuit.
This deadline is strict—missing it permanently bars compensation regardless of injury severity.
The clock starts on the date your doctor diagnosed your qualifying condition, not when you learned the bad news about water contamination.
Contact an attorney immediately to preserve your rights.
Yes, veterans receiving VA disability benefits can absolutely file civil PFAS lawsuits.
Your military benefits address service-connected disabilities, while lawsuits target chemical manufacturers like 3M and DuPont who contaminated water supplies.
Veterans from Joint Base McGuire-Dix-Lakehurst and other NJ installations often have stronger claims due to combined occupational AFFF exposure and contaminated base housing water.
Key documents include utility bills showing service addresses, property deeds or rental agreements, employment records for contaminated locations, and military service records if applicable.
Don’t worry if records are missing—attorneys use professional retrieval services to obtain documentation from closed facilities, merged companies, and historical databases.
Even without complete records, affidavits and reconstructed timelines can establish exposure.
PFAS attorneys charge absolutely nothing upfront.
They work on contingency fees, typically 33-40% of your settlement, and advance all costs including expert witnesses, medical record retrieval, and court fees.
You pay nothing unless you win.
This arrangement ensures financial constraints never prevent deserving victims from pursuing justice against well-funded chemical companies.
After filing, your case may transfer to federal multidistrict litigation in South Carolina or remain in New Jersey state court.
The discovery phase involves document production and possible depositions (often conducted locally).
Most cases settle within 12-24 months without trial.
Your attorney handles all procedural requirements while keeping you informed of settlement negotiations and key developments throughout the process.
If you or a loved one suffered health impacts from PFAS-contaminated water in New Jersey, time is running out to seek the compensation you deserve.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a New Jersey PFAS water contamination lawsuit today.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.
A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?